An enhanced prognostic score for overall survival of patients with cancer derived from a large real-world cohort - ScienceDirect

Correlation of tumor PD-L1 expression in different tissue types and outcome of PD-1-based immunotherapy in metastatic melanoma – analysis of the DeCOG prospective multicenter cohort study ADOREG/TRIM - eBioMedicine

A modified nutrition risk screening 2002 predicts the risk of death among hospitalized patients with COVID-19 - Clinical Nutrition ESPEN

Identification of comprehensive biomarkers in patients with mismatch repair-deficient Colon Adenocarcinoma based on parallel multi-omics - Laboratory Investigation

Sarcopenia Predicts Inferior Progression-Free Survival in Lymphoma Patients Treated with Autologous Hematopoietic Stem Cell Transplantation - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and

Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer (CAPSTONE-1): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial - The Lancet Oncology

Neoadjuvant immunotherapy, chemotherapy, and combination therapy in muscle-invasive bladder cancer: A multi-center real-world retrospective study - ScienceDirect

PDF) An Enhanced Prognostic Score for Overall Survival of Patients with Cancer Derived from a large Real World Cohort

Treatment patterns and outcomes of patients with relapsed or refractory follicular lymphoma receiving three or more lines of systemic therapy (LEO CReWE): a multicentre cohort study - The Lancet Haematology

Third-line Life-prolonging Drug Treatment in a Real-world Metastatic Castration-resistant Prostate Cancer Population: Results from the Dutch Castration-resistant Prostate Cancer Registry - European Urology Focus